HomeBLACU • NASDAQ
add
Bellevue Life Sciences Acquisition Units
Previous close
$11.72
Day range
$11.59 - $11.73
Year range
$10.70 - $12.50
Market cap
45.91M USD
Avg Volume
5.70K
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 454.13K | 10.65% |
Net income | -230.96K | -395.41% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -24.89% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.24K | -78.89% |
Total assets | 20.93M | -70.99% |
Total liabilities | 26.68M | -64.23% |
Total equity | -5.75M | — |
Shares outstanding | 4.04M | — |
Price to book | -8.25 | — |
Return on assets | -5.46% | — |
Return on capital | 31.55% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -230.96K | -395.41% |
Cash from operations | -226.88K | -58.41% |
Cash from investing | -150.00K | — |
Cash from financing | 270.00K | 35.00% |
Net change in cash | -106.88K | -288.26% |
Free cash flow | -10.55K | -107.50% |
About
Founded
2020
Headquarters
Website
